We currently have an immediate opening for a Toxicologist at our location located near Evansville, IN close to Southern Indiana University, Evansville.
BASi (Tox)
Shelley Nance
10424 Middle Mount Vernon Rd.
Mt Vernon, IN 47620
snance@bioanalytical.com
Fax: 812-985-9103
www.basinc.com
NO PHONE CALLS PLEASE
BASi offers competitive compensation and benefits. Interested candidates please forward resumes, along with salary expectations to: snance@bioanalytical.com
All applicants must be currently authorized to work in the United States. No visa sponsorship available.
BASi is an Equal Opportunity Employer
05Oct2009
Qualifications include a PhD and/or DVM (DABT preferred) with at least 2 years of preclinical toxicology experience directing non-clinical in vivo studies at a CRO or pharmaceutical company. Experience may be substituted for education. Essential skills include: leadership; excellent communication including fluent command of the English language, writing and speaking; good organizational skills; knowledge and experience with Good Laboratory Practices; experience using computer applications; and data analysis skills are mandatory.
Responsibilities include but are not limited to:
Maintaining and completing multiple projects simultaneously,
Protocol development,
Communicating with staff, management, and clients,
Analysis, interpretation, and reporting of data from non-clinical studies,
Direct and/or supervise the work of technical staff in accordance with the GLP’s and SOP’s
Maintain knowledge of FDA and other regulatory guidelines,
Proactive recognition and resolution of any issues affecting the conduct of non-clinical studies,
Perform other duties as directed by the Director of Toxicology,
Support and participate in other company initiatives as directed by management.
BASi is a contract research organization providing research and development resources to many of the leading pharmaceutical, medical device, and biotechnology companies in the world. BASi offers an efficient cost-alternative to its client’s internal product development, compliance, and quality control programs. Outsourced drug development services provided to the international pharmaceutical industry comprise approximately 75% of our revenues.